ConductScience.org, home

Paper15565337

Characterization of natural peptide ligands from HLA-DP2: new insights into HLA-DP peptide-binding motifs.

Díaz G and 4 others. Immunogenetics, 2005. Cited by 24 papers, by iCite.

Cite this record

ConductScience Library. Characterization of natural peptide ligands from HLA-DP2: new insights into HLA-DP peptide-binding motifs. Papers, record 15565337. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/15565337

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Characterization of natural peptide ligands from HLA-DP2: new insights into HLA-DP peptide-binding motifs.
PubMed
Journal
Immunogenetics
PubMed
Year
2005
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
24
iCite
Relative citation ratio, by iCite
0.55
iCite
Revised in PubMed
2018-11-13
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Díaz GGema
2Cañas BBenito
3Vazquez JJesús
4Nombela CCésar
5Arroyo JJavier

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
HLA-DP AntigensMajor topic
Amino Acid Motifs
Amino Acid Sequence
Binding Sites
HLA-DP beta-Chains
Ligands
Molecular Sequence Data
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization

Source PubMed

Download CSV of topics

References25

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
12512583A specific HLA-DP beta allele is associated with pauciarticular juvenile rheumatoid arthritis but not adult rheumatoid arthritis.Proc Natl Acad Sci U S A1989https://conductscience.org/library/papers/2512583PubMed
211741697Perspectives: towards a peptide-based vaccine against hepatitis C virus.Mol Immunol2001https://conductscience.org/library/papers/11741697PubMed
37672826Naturally processed HLA-DR9/DR53 (DRB1*0901/DRB4*0101)-bound peptides.Immunogenetics1995https://conductscience.org/library/papers/7672826PubMed
410427976HLA-DP molecules bind cobalt: a possible explanation for the genetic association with hard metal disease.Eur J Immunol1999https://conductscience.org/library/papers/10427976PubMed
51363421HLA-A and DPB1 loci confer susceptibility to Graves' disease.Hum Immunol1992https://conductscience.org/library/papers/1363421PubMed
612391221HLA-DR4 molecules in neuroendocrine epithelial cells associate to a heterogeneous repertoire of cytoplasmic and surface self peptides.J Immunol2002https://conductscience.org/library/papers/12391221PubMed
710028688High-sensitivity analysis and sequencing of peptides and proteins by quadrupole ion trap mass spectrometry.J Mass Spectrom1999https://conductscience.org/library/papers/10028688PubMed
812622773Population of the HLA ligand database.Tissue Antigens2003https://conductscience.org/library/papers/12622773PubMed
912469335Application of proteomics for fast identification of species-specific peptides from marine species.Proteomics2002https://conductscience.org/library/papers/12469335PubMed
107513525Origin, structure and motifs of naturally processed MHC class II ligands.Curr Opin Immunol1994https://conductscience.org/library/papers/7513525PubMed
1112021132Molecular modeling of eluted peptides from DQ6 molecules (DQB1*0602 and DQB1*0604) negatively and positively associated with type 1 diabetes.Ann N Y Acad Sci2002https://conductscience.org/library/papers/12021132PubMed
128105536HLA-DPB1 glutamate 69: a genetic marker of beryllium disease.Science1993https://conductscience.org/library/papers/8105536PubMed
137890324MHC ligands and peptide motifs: first listing.Immunogenetics1995https://conductscience.org/library/papers/7890324PubMed
148299686Identification of an HLA-DQ2 peptide binding motif and HLA-DPw3-bound self-peptide by pool sequencing.Eur J Immunol1994https://conductscience.org/library/papers/8299686PubMed
1514617029Detailed analysis of the effects of Glu/Lys beta69 human leukocyte antigen-DP polymorphism on peptide-binding specificity.Tissue Antigens2003https://conductscience.org/library/papers/14617029PubMed
166933474Gamma ray-induced loss of expression of HLA and glyoxalase I alleles in lymphoblastoid cells.Proc Natl Acad Sci U S A1980https://conductscience.org/library/papers/6933474PubMed
1712697658Functional analysis of HLA-DP polymorphism: a crucial role for DPbeta residues 9, 11, 35, 55, 56, 69 and 84-87 in T cell allorecognition and peptide binding.Int Immunol2003https://conductscience.org/library/papers/12697658PubMed
188119729Pool sequencing of natural HLA-DR, DQ, and DP ligands reveals detailed peptide motifs, constraints of processing, and general rules.Immunogenetics1994https://conductscience.org/library/papers/8119729PubMed
198436419HLA-DP/DR interaction in early onset pauciarticular juvenile chronic arthritis.Immunogenetics1993https://conductscience.org/library/papers/8436419PubMed
208672555Natural ligand motifs of closely related HLA-DR4 molecules predict features of rheumatoid arthritis associated peptides.Biochim Biophys Acta1996https://conductscience.org/library/papers/8672555PubMed

See all 25 referencesDownload CSV of references

Cited by17

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 24 citations.

PMIDTitleJournalYearIn PapersSource
29520276Alloreactive T Cell Receptor Diversity against Structurally Similar or Dissimilar HLA-DP Antigens Assessed by Deep Sequencing.Front Immunol2018https://conductscience.org/library/papers/29520276PubMed
26685315Beryllium-Induced Hypersensitivity: Genetic Susceptibility and Neoantigen Generation.J Immunol2016https://conductscience.org/library/papers/26685315PubMed
25369028Chronic Beryllium Disease: revealing the role of beryllium ion and small peptides binding to HLA-DP2.PLoS One2014https://conductscience.org/library/papers/25369028PubMed
24995984Structural basis of chronic beryllium disease: linking allergic hypersensitivity and autoimmunity.Cell2014https://conductscience.org/library/papers/24995984PubMed
23978481T cell recognition of beryllium.Curr Opin Immunol2013https://conductscience.org/library/papers/23978481PubMed
23797096Identification of beryllium-dependent peptides recognized by CD4+ T cells in chronic beryllium disease.J Exp Med2013https://conductscience.org/library/papers/23797096PubMed
22983897Structural basis of metal hypersensitivity.Immunol Res2013https://conductscience.org/library/papers/22983897PubMed
22972925Chronic beryllium disease, HLA-DPB1, and the DP peptide binding groove.J Immunol2012https://conductscience.org/library/papers/22972925PubMed
21752305Peptide binding prediction for the human class II MHC allele HLA-DP2: a molecular docking approach.BMC Struct Biol2011https://conductscience.org/library/papers/21752305PubMed
20959457HLA-DP, HLA-DQ, and HLA-DR have different requirements for invariant chain and HLA-DM.J Biol Chem2010https://conductscience.org/library/papers/20959457PubMed
20427584Linking genetic susceptibility and T cell activation in beryllium-induced disease.Proc Am Thorac Soc2010https://conductscience.org/library/papers/20427584PubMed
20356827Crystal structure of HLA-DP2 and implications for chronic beryllium disease.Proc Natl Acad Sci U S A2010https://conductscience.org/library/papers/20356827PubMed
20139279Five HLA-DP molecules frequently expressed in the worldwide human population share a common HLA supertypic binding specificity.J Immunol2010https://conductscience.org/library/papers/20139279PubMed
19191908Role of high-affinity HLA-DP specific CLIP-derived peptides in beryllium binding to the HLA-DPGlu69 berylliosis-associated molecules and presentation to beryllium-sensitized T cells.Immunology2009https://conductscience.org/library/papers/19191908PubMed
18334973HLA-associated susceptibility to childhood B-cell precursor ALL: definition and role of HLA-DPB1 supertypes.Br J Cancer2008https://conductscience.org/library/papers/18334973PubMed
18245836An asymmetric model of heterozygote advantage at major histocompatibility complex genes: degenerate pathogen recognition and intersection advantage.Genetics2008https://conductscience.org/library/papers/18245836PubMed
17622527HLA-DPB1 supertype-associated protection from childhood leukaemia: relationship to leukaemia karyotype and implications for prevention.Cancer Immunol Immunother2008https://conductscience.org/library/papers/17622527PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
HLA-DPB13115PubTator's text mininghttps://conductscience.org/library/genes/3115

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/15565337

GET https://conductscience.org/api/papers/v1/15565337/references?page=2